SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-136236
Filing Date
2020-05-07
Accepted
2020-05-07 16:10:45
Documents
3
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d927651d8k.htm 8-K 19380
2 EX-99.1 d927651dex991.htm EX-99.1 51076
3 GRAPHIC g927651g0507144855152.jpg GRAPHIC 4527
  Complete submission text file 0001193125-20-136236.txt   78028
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 20856447
SIC: 2836 Biological Products, (No Diagnostic Substances)